Thrive Capital Management (Pennsylvania)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,538
| Closed | -$515K | – | 126 |
|
|
2024
Q3 | $515K | Sell |
3,538
-68
| -2% | -$9.9K | 0.24% | 121 |
|
|
2024
Q2 | $495K | Buy |
+3,606
| New | +$495K | 0.23% | 125 |
|
|
2024
Q1 | – | Sell |
-14,231
| Closed | -$1.93M | – | 155 |
|
|
2023
Q4 | $1.93M | Sell |
14,231
-1,326
| -9% | -$180K | 1.03% | 32 |
|
|
2023
Q3 | $1.9M | Buy |
15,557
+2,693
| +21% | +$329K | 1.05% | 29 |
|
|
2023
Q2 | $1.63M | Sell |
12,864
-245
| -2% | -$31.1K | 0.93% | 33 |
|
|
2023
Q1 | $1.67M | Sell |
13,109
-611
| -4% | -$77.7K | 1.05% | 27 |
|
|
2022
Q4 | $1.8M | Sell |
13,720
-1,475
| -10% | -$194K | 1.18% | 21 |
|
|
2022
Q3 | $1.78M | Sell |
15,195
-806
| -5% | -$94.3K | 1.2% | 20 |
|
|
2022
Q2 | $1.88M | Sell |
16,001
-97
| -0.6% | -$11.4K | 1.3% | 20 |
|
|
2022
Q1 | $2.1M | Buy |
16,098
+6,195
| +63% | +$807K | 1.27% | 23 |
|
|
2021
Q4 | $1.51M | Buy |
+9,903
| New | +$1.51M | 0.98% | 25 |
|